Literature DB >> 10850639

Real-time monitoring of nitric oxide in ischemia-reperfusion rat kidney.

M Saito1, I Miyagawa.   

Abstract

In this study we attempted to clarify the release of nitric oxide (NO) and its role in the ischemia-reperfusion rat kidney. After right nephrectomy, male Wistar rats were divided into four groups: one sham operated and three groups who underwent ischemia (30 min) and reperfusion of the left renal artery. Thirty minutes prior to ischemia-reperfusion, two groups were injected intraperitoneally with 10 and 30 mg/kg of NG-nitro-L-arginine methylester (L-NAME). Real-time monitoring of blood flow and NO release in the rat kidney was measured with a laser Doppler flowmeter and an NO-selective electrode, respectively. Serum creatinine and blood urea nitrogen (BUN) levels were measured 1 and 7 days after the induction of ischemia-reperfusion. Clamping of the renal artery decreased blood flow to 1-5% of the basal level measured before clamping. After removal of the clip, the blood flow of the 30 mg/kg L-NAME rats was significantly lower than that of the controls. Immediately following the clipping of the renal artery, NO release rapidly increased. After removing the clip, NO release immediately returned to three-quarters of the basal level. Serum creatinine and BUN levels of the ischemia-reperfusion rats were slightly but not significantly higher and those of 30 mg L-NAME rats were significantly higher than those of the control or ischemia-reperfusion rats 1 day and 7 days after ischemia-reperfusion. Our data suggest that NO acts as a cytoprotective agent in ischemia-reperfusion injury of the rat kidney.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10850639     DOI: 10.1007/s002400050153

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  6 in total

1.  RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury.

Authors:  Andrew M Siedlecki; Xiaohua Jin; Winston Thomas; Keith A Hruska; Anthony J Muslin
Journal:  Kidney Int       Date:  2011-03-16       Impact factor: 10.612

2.  The effects of the nitric oxide donor molsidomine prevent in warm ischemia-reperfusion injury of the rat renal--a functional and histophatological study.

Authors:  H Oztürk; M Aldemir; H Büyükbayram; A I Dokucu; S Otçu
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 3.  Renal endothelial dysfunction in acute kidney ischemia reperfusion injury.

Authors:  David P Basile; Mervin C Yoder
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2014

4.  Deletion of the Gamma Subunit of ENaC in Endothelial Cells Does Not Protect against Renal Ischemia Reperfusion Injury.

Authors:  Stephanie M Mutchler; Mahpara Hasan; Donald E Kohan; Thomas R Kleyman; Roderick J Tan
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

5.  Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury.

Authors:  Yosuke Nakayama; Seiji Ueda; Sho-ichi Yamagishi; Nana Obara; Kensei Taguchi; Ryotaro Ando; Yusuke Kaida; Ryuji Iwatani; Kumiko Kaifu; Miyuki Yokoro; Maki Toyonaga; Takuo Kusumoto; Kei Fukami; Seiya Okuda
Journal:  Kidney Int       Date:  2013-10-09       Impact factor: 10.612

Review 6.  Mitochondria-Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion Injury.

Authors:  Aleksandra Kezic; Ivan Spasojevic; Visnja Lezaic; Milica Bajcetic
Journal:  Oxid Med Cell Longev       Date:  2016-05-24       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.